triazoles has been researched along with Chondrosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gui, T; He, QY; Huang, X; Li, Z; Liu, N; Liu, RX; Liu, W; Ross, RD; Sang, Y; Tang, W; Tong, KL; Wu, CJ; Xu, QT; Yang, J; Zha, ZG; Zhang, HT | 1 |
Gui, T; He, QY; Li, T; Li, YH; Liang, GH; Sang, Y; Yang, J; Zha, ZG; Zhang, HT | 1 |
2 other study(ies) available for triazoles and Chondrosarcoma
Article | Year |
---|---|
Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1.
Topics: Adaptor Proteins, Signal Transducing; Animals; Azepines; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Chondrosarcoma; Cyclin-Dependent Kinase Inhibitor p21; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Proteins; rho GTP-Binding Proteins; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays; YAP-Signaling Proteins | 2021 |
The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Azepines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Chondrosarcoma; Cyclin-Dependent Kinase Inhibitor p21; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Phosphoproteins; Proteins; Proto-Oncogene Proteins c-myc; RNA Interference; Signal Transduction; Transcription Factors; Triazoles; YAP-Signaling Proteins | 2017 |